QGMD Stock Overview
Qatari German Company for Medical Devices (Q.P.S.C.) manufactures and sells single use disposable syringes in the Middle East.
Qatari German Company for Medical Devices (Q.P.S.C.) Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||ر.ق1.77|
|52 Week High||ر.ق4.13|
|52 Week Low||ر.ق1.35|
|1 Month Change||22.57%|
|3 Month Change||-16.03%|
|1 Year Change||-41.54%|
|3 Year Change||181.05%|
|5 Year Change||116.56%|
|Change since IPO||-26.27%|
Recent News & Updates
Qatari German Company for Medical Devices (Q.P.S.C.) (DSM:QGMD) Shareholders Will Want The ROCE Trajectory To Continue
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
|QGMD||QA Medical Equipment||QA Market|
Return vs Industry: QGMD underperformed the QA Medical Equipment industry which returned -26.1% over the past year.
Return vs Market: QGMD underperformed the QA Market which returned 16.6% over the past year.
|QGMD Average Weekly Movement||7.8%|
|Medical Equipment Industry Average Movement||5.9%|
|Market Average Movement||4.6%|
|10% most volatile stocks in QA Market||7.0%|
|10% least volatile stocks in QA Market||3.1%|
Stable Share Price: QGMD is more volatile than 90% of QA stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: QGMD's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of QA stocks.
About the Company
Qatari German Company for Medical Devices (Q.P.S.C.) manufactures and sells single use disposable syringes in the Middle East. The company offers Q JectUltra, an insulin syringe serving as a tool in diabetic care; Q Flow for infusion therapy; Q Need, a single use hypodermic needle; Q Ject, a single use syringe for the curative medications; and Q Safe, a re-use prevention syringe. It also trades in medical consumables, medical equipment, medical furniture, tools, and supplies.
Qatari German Company for Medical Devices (Q.P.S.C.) Fundamentals Summary
|QGMD fundamental statistics|
Is QGMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|QGMD income statement (TTM)|
|Cost of Revenue||ر.ق30.55m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 10, 2022
|Earnings per share (EPS)||0.011|
|Net Profit Margin||2.94%|
How did QGMD perform over the long term?See historical performance and comparison
Is QGMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for QGMD?
Other financial metrics that can be useful for relative valuation.
|What is QGMD's n/a Ratio?|
Price to Sales Ratio vs Peers
How does QGMD's PS Ratio compare to its peers?
|QGMD PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
COMFORT Comfort Gloves Berhad
546 Medtecs International
8K7 UG Healthcare
CAREPLS Careplus Group Berhad
QGMD Qatari German Company for Medical Devices (Q.P.S.C.)
Price-To-Sales vs Peers: QGMD is expensive based on its Price-To-Sales Ratio (4.9x) compared to the peer average (0.4x).
Price to Earnings Ratio vs Industry
How does QGMD's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price-To-Sales vs Industry: QGMD is expensive based on its Price-To-Sales Ratio (4.9x) compared to the Asian Medical Equipment industry average (3.3x)
Price to Sales Ratio vs Fair Ratio
What is QGMD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||4.9x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate QGMD's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of QGMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: QGMD (QAR1.77) is trading above our estimate of fair value (QAR1.1)
Significantly Below Fair Value: QGMD is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Qatari German Company for Medical Devices (Q.P.S.C.) forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Qatari German Company for Medical Devices (Q.P.S.C.) has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Take a look at our analysis of QGMD’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
How has Qatari German Company for Medical Devices (Q.P.S.C.) performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: QGMD has high quality earnings.
Growing Profit Margin: QGMD's current net profit margins (2.9%) are lower than last year (12.7%).
Past Earnings Growth Analysis
Earnings Trend: QGMD has become profitable over the past 5 years, growing earnings by 44.6% per year.
Accelerating Growth: QGMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: QGMD had negative earnings growth (-67%) over the past year, making it difficult to compare to the Medical Equipment industry average (10.8%).
Return on Equity
High ROE: QGMD's Return on Equity (3.7%) is considered low.
Discover strong past performing companies
How is Qatari German Company for Medical Devices (Q.P.S.C.)'s financial position?
Financial Health Score0/6
Financial Health Score 0/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: QGMD's short term assets (QAR53.0M) do not cover its short term liabilities (QAR73.8M).
Long Term Liabilities: QGMD's short term assets (QAR53.0M) do not cover its long term liabilities (QAR78.8M).
Debt to Equity History and Analysis
Debt Level: QGMD's net debt to equity ratio (414.5%) is considered high.
Reducing Debt: QGMD's debt to equity ratio has increased from 149.3% to 427.7% over the past 5 years.
Debt Coverage: QGMD's debt is not well covered by operating cash flow (4.9%).
Interest Coverage: QGMD's interest payments on its debt are not well covered by EBIT (1.3x coverage).
Discover healthy companies
What is Qatari German Company for Medical Devices (Q.P.S.C.) current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate QGMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate QGMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if QGMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if QGMD's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: QGMD is not paying a notable dividend for the QA market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as QGMD has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Mr. Eisa Khalid Al-Maslamani serves as Managing Director and Executive Director at Qatari German Company for Medical Devices Q.P.S.C. He served as Independent Director at Qatari German Company for Medical...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Qatari German Company for Medical Devices (Q.P.S.C.)'s employee growth, exchange listings and data sources
- Name: Qatari German Company for Medical Devices (Q.P.S.C.)
- Ticker: QGMD
- Exchange: DSM
- Founded: 2000
- Industry: Health Care Supplies
- Sector: Healthcare
- Implied Market Cap: ر.ق203.858m
- Shares outstanding: 115.50m
- Website: https://www.qgmd.com
- Qatari German Company for Medical Devices (Q.P.S.C.)
- Building Number 136
- Street Number 54
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/07 00:00|
|End of Day Share Price||2022/08/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.